{
    "root": "dcb793e7-ec95-4c62-95e5-28b3ba29aad0",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "FLUOCINONIDE",
    "value": "20250320",
    "ingredients": [
        {
            "name": "FLUOCINONIDE",
            "code": "2W4A77YPAN"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "DIISOPROPYL ADIPATE",
            "code": "P7E6YFV72X"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        }
    ],
    "indications": "Fluocinonide topical solution USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.",
    "contraindications": "Fluocinonide topical solution USP, 0.05% is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition.\n                  Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.\n                  If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.",
    "warningsAndPrecautions": "Fluocinonide Topical Solution USP, 0.05% is a clear, colorless to pale yellow solution supplied in plastic squeeze bottle:\n                  \n                  60 mL - NDC 70752-154-05\n                  \n                  Tamper Evident - Do not use if shrink seal is broken or missing\n                  Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F). See USP Controlled Room Temperature. Avoid excess heat, above 40°C (104°F).\n                  \n                  Manufactured by:\n                     Quagen Pharmaceuticals LLC\n                     \n                  West Caldwell, NJ 07006\n                  \n                  52037  \n                  Rev. 09/21",
    "adverseReactions": "Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation."
}